Docetaxel

tumor necrosis factor (ligand) superfamily, member 11 ; Mus musculus







3 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 19082914 Docetaxel inhibits bone resorption through suppression of osteoclast formation and function in different manners. 2009 1
2 18324676 RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastases model. 2008 Jun 1 2
3 18606716 RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis. 2008 Jul 3